AB0720 IMPACT OF SPONDYLOARTHRITIS ON THE MALE SEXUAL FUNCTION: LIMITING FACTORS. (June 2019)

• Record Type: Journal Article
• Authors: Fazaa, Alia; Rouached, Leila; Khereddine, Mourad Dali; Miladi, Saoussen; Ouenniche, Kmar; Souabni, Leila; Chekili, Selma; Kassab, Salma; Abdelghani, Kawther Ben; Yassine, Nouira; Laatar, Ahmed
• Is Part Of: Annals of the rheumatic diseases. Volume 78(2019)Supplement 2
• Page Start: 1823
• Page End: 1823
• Publication Date: 2019-06
• Subjects: Rheumatism -- Periodicals; 616.723005
• DOI: 10.1136/annrheumdis-2019-eular.5624
• Languages: English
• ISSNs: 0003-4967

Abstract

Abstract : Background: The impact of Spondyloarthritis (SpA) on patients' sexual life and erectile function has been gathering the attention of the scientific community over the last decade 1, 2 . Several factors may condition sexual function for SpA patients: microangiopathy, pain, decreased range of motion, joint swelling and extraarticular features such as fatigue. Objectives: To assess the erectile function and the sexual desire in a cohort of male patients with SpA and to identify the factors related to the disease limiting the sexual life. Methods: This is a cross sectional study including sexually active male patients with SpA (ASAS criteria). A questionnaire was performed, consisting in two parts. One part filled by a rheumatologist with data of the disease (comorbidities, the presence of a coxitis, disease activity (BASDAI and aSDAS), function index (BASFI) and current treatment). The other part consisted in a questionnaire filled by an urologist, with data on pain during intercourse, the international index of erectile function (IEEF5), intensity and frequency of sexual desire and disease impact on private life. For statistical analysis, we used Khi 2 -test for qualitative variables and Student-test for quantitative variables. A p value ≤0.05 was considered significant. Results: We included 37 male patients with SpA, 18.9% had psoriatic arthritis, 51.4% had ankylosing spondylitis and 29.7% had inflammatory bowel disease spondyloarthritis. The mean age was 42.5 ± 1.8 years. Sixty two percent of patients were married. Mean disease duration was 11.4 ± 7.1 years. The mean disease activity and functional scores were as follow: BASDAI=2.57 ± 1.96, aSDAS CRP=2.36 ± 1.09, BASFI=2.59 ± 2.54). For the treatment side: 40.5% were on NSAIDs, 70.3% on csDMARDs and 56.8% of patients were on biotherapy (33.3% on adalimumab, 52.4% on infliximab and 14.3% on Etanercept). The mean visual analog pain scale during intercourse was 2.97 ± 1.89 and the erectile function was deteriorated in 80.6% of patients. Conclusion: Our results suggest the impact of SpA on patients' sexual function. Pain during intercourse and the limitation of the sexual desire were the most limiting factors of the sexual function. References: [1] Tristano aG. The impact of rheumatic diseases on sexual function. Rheumatol int2009;29:853–60. [2] Bal S, et al. sexual functions in ankylosing spondylitis. Rheumatol int2011;31(7):889-94. Disclosure of interests: None declared